4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
Product Information
Molecular Formula
C13H17BO3
Molecular Weight
232.08328
Description
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde is a remarkable biomedical agent. With its exceptional pharmaceutical potential, this compound serves as a pivotal intermediate in medicinal formulations, facilitating the synthesis of groundbreaking drugs targeting cancer, inflammation, and neurological anomalies. Its distinctive and intricate chemical configuration imparts invaluable contributions to the realm of biomedicine research, propelling the advancement of revolutionary therapeutic approaches and pharmaceutical innovations.
Synonyms
128376-64-7; 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde; 4-Formylphenylboronicacidpinacolester; 4-formylbenzeneboronicacid,pinacolester; 4-formylphenylboronicacidpinacolate; 4-formylphenylboronicacidpinacolcyclicester
IUPAC Name
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)C=O
InChI
InChI=1S/C13H17BO3/c1-12(2)13(3,4)17-14(16-12)11-7-5-10(9-15)6-8-11/h5-9H,1-4H3
InChI Key
DMBMXJJGPXADPO-UHFFFAOYSA-N
Boiling Point
341.3°C at 760 mmHg
Melting Point
55-58°C
Flash Point
Not applicable
Purity
95%
Density
1.06g/cm3
Appearance
Light yellow powder
Safety Information
Hazards
H317
Precautionary Statement
P280
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
2
Exact Mass
232.1270746 g/mol
Monoisotopic Mass
232.1270746 g/mol
Topological Polar Surface Area
35.5Ų
Heavy Atom Count
17
Formal Charge
0
Complexity
277
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-114085241-A | Probe for detecting and identifying tea polyphenol and preparation method and application thereof | 2021-11-18 |
| CN-113831339-A | Perylene bisimide derivative fluorescent probe, preparation method and application thereof | 2021-10-15 |
| CN-113788783-A | Self-reporting photosensitizer and preparation method and application thereof | 2021-10-12 |
| CN-112694394-A | Ultrasensitive multi-output signal biosensor and preparation method and application thereof | 2020-08-25 |
| WO-2022040293-A1 | Substituted heteroaryl compounds useful as inhibitors of tlr9 | 2020-08-19 |
| WO-2022033991-A1 | 5-amino substituted triazoles as pest control agents | 2020-08-13 |
| CN-112142766-A | Benzoindole hydrogen peroxide fluorescent probe and preparation method thereof | 2020-08-10 |
| CN-111662316-A | Indole hydrogen peroxide fluorescent probe and preparation method thereof | 2020-06-30 |
| CN-111689996-A | Quinoline hydrogen peroxide fluorescent probe and preparation method thereof | 2020-06-30 |
| WO-2021231474-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | 2020-05-12 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 23125655 | 2012-10-01 | 2,2'-{[(2,2'-Dieth-oxy-1,1'-binaphthalene-6,6'-di-yl)bis-(4,1-phenyl-ene)]bis-(methan-ylyl-idene)}dimalononitrile | Acta crystallographica. Section E, Structure reports online |
| 22669190 | 2012-06-01 | 1-[5-(4,5-Dimethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]ethanone and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | Acta crystallographica. Section C, Crystal structure communications |
